GlaxoSmithKline Pharmaceuticals gains on reporting 76% rise in Q3 net profit

11 Feb 2016 Evaluate

Glaxosmithkline Pharmaceuticals is currently trading at Rs. 3242.00, up by 3.05 points or 0.09 % from its previous closing of Rs. 3238.95 on the BSE.

The scrip opened at Rs. 3225.10 and has touched a high and low of Rs. 3242.00 and Rs. 3195.00 respectively. So far 1475 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 3825.00 on 05-Aug-2015 and a 52 week low of Rs. 2965.65 on 27-Apr-2015.

Last one week high and low of the scrip stood at Rs. 3310.00 and Rs. 3175.00 respectively. The current market cap of the company is Rs. 27210.42 crore.

The promoters holding in the company stood at 75.00% while Institutions and Non-Institutions held 11.74% and 13.26% respectively.The company has reported 76.38% rise in its net profit at Rs 79.90 crore for the quarter ended December 31, 2015 as compared to Rs 45.30 crore for the same quarter in the previous year. Total income of the company has increased by 10.66% to Rs 762.06 crore for the quarter under review from Rs 688.63 crore for the corresponding quarter of the previous year. 

GlaxoSmithKline Pharmaceuticals is a subsidiary of GlaxoSmithKline plc, one of the world's leading research-based pharmaceutical and healthcare companies, committed to improving the quality of human life by enabling people to do more, feel better and live longer.

Glaxosmithkline Phar Share Price

1995.45 -2.15 (-0.11%)
14-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1545.25
Dr. Reddys Lab 5861.00
Cipla 1356.95
Zydus Lifesciences 984.75
Lupin 1635.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.